← Back to Clinical Trials
Recruiting NCT05231876

NCT05231876 French Wilson Disease Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05231876
Status Recruiting
Phase
Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Condition Wilson Disease
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2005-01-01
Primary Completion 2030-01-01

Eligibility & Interventions

Sex All sexes
Min Age 0 Years
Max Age 99 Years
Study Type OBSERVATIONAL
Interventions
Recording of pathology-related information on the Wilson Register

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2005-01-01 with a primary completion date of 2030-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This registry concerns adults and children with Wilson's disease. The collection of a large amount of data will allow a better understanding of the epidemiology of this rare disease, in particular the age of onset according to the hepatic or hepato-neurological forms, but also the geographical distribution of patients consulting in France. This database will also make it possible to know all the therapies prescribed to "Wilsonian" patients. The genetic study of these patients will make it possible to specify the various genetic mutations involved in Wilson's disease. The information (clinical, biological, radiological and genetic) relating to the disease will be entered by a doctor or a professional specialising in Wilson's disease.

Eligibility Criteria

Inclusion Criteria: * All patients suffering from Wilson disease Exclusion Criteria: * Lack of written consent from the patient or their legal representative

Contact & Investigator

Central Contact

Aurélia Poujois, MD, PhD

✉ apoujois@for.paris

📞 (0)148036656

Frequently Asked Questions

Who can join the NCT05231876 clinical trial?

This trial is open to participants of all sexes, aged 0 Years or older, up to 99 Years, studying Wilson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05231876 currently recruiting?

Yes, NCT05231876 is actively recruiting participants. Contact the research team at apoujois@for.paris for enrollment information.

Where is the NCT05231876 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT05231876 clinical trial?

NCT05231876 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology